Connected Drug Delivery Devices Market Size US$ 3,517.0 Million, Growth Rate (CAGR) of 33.6% and Forecast 2023-2028
According to IMARC Group’s latest report, titled “ Connected Drug Delivery Devices Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 ”, the global connected drug delivery devices market size reached US$ 652.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 3,517.0 Million by 2028, exhibiting a growth rate (CAGR) of 33.6% during 2023-2028. Connected drug delivery devices refer to smart wireless electronic systems that support patient supervision and counseling in home settings. They are equipped with dose reminders, adherence trackers, sensors, and monitoring tools to provide instant feedback and education tools for personalized sufferer care. Connected drug delivery devices are convenient and save costs associated with clinic-based treatment. Consequently, they are widely utilized in the remote monitoring of patients with asthma, diabetes, hepatitis C, hypertension, tuberculosis, clinically isolated syndrome, multipl...